Multidisciplinary decision-making regarding chemotherapy for lung cancer patients-An age-based comparison
European Journal of Cancer Care2017Vol. 27(1), pp. e12768–e12768
Citations Over TimeTop 20% of 2017 papers
Karlijn J.G. Schulkes, Marije E. Hamaker, J.-W.J. Lammers, Marcel Th. M. van Rens, M.L. Geerts, Leontine J. R. van Elden
Abstract
Optimising decision-making in elderly patients is becoming increasingly urgent. We analysed treatment decisions and course of therapy for patients with lung cancer in different age categories: 75 years in 66%. For 44% of all patients treated with chemotherapy, unplanned hospital admissions were required: in 42% for the patients 75 years. The decision-making process and course of treatment for lung cancer vary per age category. In particular, patients between 65 and 75 years of age might be more frail than initially thought. Age and frailty are important characteristics that need more attention.
Related Papers
- → Outcome of patients with gastroschisis managed with and without multidisciplinary teams in Canada(2014)12 cited
- → Implementing a Multidisciplinary Prone Positioning Team(2021)5 cited
- → The Multidisciplinary Team Conference(2021)1 cited
- → The Role of the Multidisciplinary Team(2008)
- → Using the Multidisciplinary Team(2013)